Development of an oral nanovaccine for dogs against Echinococcus granulosus.
Leroux M, Benavides U, Hellel-Bourtal I, Silvarrey C, Milhau N, Marchal T, Bourgeois S, Lawton P, Briançon S, Petavy AF, Lahmar S, Esteves A, Almouazen E, Azzouz-Maache S.
Leroux M, et al. Among authors: benavides u.
Eur J Pharm Biopharm. 2023 Nov;192:185-195. doi: 10.1016/j.ejpb.2023.09.012. Epub 2023 Sep 26.
Eur J Pharm Biopharm. 2023.
PMID: 37769880